This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2016
  • /
  • 04
  • /
  • Abbott's ARCHITECT STAT High Sensitive Troponin-I ...
Drug news

Abbott's ARCHITECT STAT High Sensitive Troponin-I (hsTnl) test may detect troponin in patients with stress induced ischaemia.

Read time: 1 mins
Last updated:4th Apr 2016
Published:4th Apr 2016
Source: Pharmawand

The stresses of life have long been thought to increase a person's risk of heart disease. But the question remains how to measure the impact of different types of stress on the heart. Now, new research conducted at Emory University shows that Abbott's ARCHITECT STAT High Sensitive Troponin-I (hsTnl) test may detect whether stress -mental and physical - leads to an inadequate oxygen supply to the heart among people with coronary artery disease.

Results from clinical trial data presented at the American College of Cardiology 65th Annual Scientific Session show that patients developing stress-induced ischemia (inadequate oxygen flow to the heart) are likely to have high levels of troponin, a protein that at increased levels can indicate injury to the heart. Over time, if there is a mismatch in oxygen flow to the heart, there is the potential to damage the muscle and lead to serious health issues, such as heart attack, heart failure or even death. High sensitive troponin tests, including Abbott's ARCHITECT STAT High Sensitive Troponin-I (hsTnI) test used in this study, are commercially available outside of the United States and in development in the United States .

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Related news and insights